Jascayd 18 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F7VH5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,915
Award facts
- Contract value 100% obligated
- $10,914.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,914.63 to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) for JASCAYD 18 mg tablets in quantities of 60 units. This is a firm fixed-price, non-set-aside contract with a completion date of February 11, 2026, and was awarded on January 21, 2026. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and veteran healthcare systems.
This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at up to $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs worldwide. The contract demonstrates Amerisourcebergen Drug Corp's proven capability to compete successfully in open competition and efficiently fulfill essential pharmaceutical requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F7VH5?
SPE2DR26F7VH5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F7VH5 worth?
The government has obligated $10,915 on SPE2DR26F7VH5.
Is contract SPE2DR26F7VH5 an order under another contract?
Yes. SPE2DR26F7VH5 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VH5 competed?
The extent of competition for SPE2DR26F7VH5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award